Trials / Sponsors / Trefoil Therapeutics, Inc.
Trefoil Therapeutics, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Dose Escalation TTHX1114 Ophthalmic Solution Corneal Epithelial Degeneration | Phase 1 | 2022-12-06 |
| Completed | A Safety and Efficacy Trial of TTHX1114 in People With CED Corneal Endothelial Dystrophy | Phase 2 | 2021-11-30 |
| Completed | TTHX1114(NM141) in Combination With DWEK/DSO Fuchs' Endothelial Dystrophy, Fuchs Dystrophy, Fuchs | Phase 2 | 2021-02-01 |
| Completed | A Phase 1/ Phase 2 Study of TTHX1114(NM141) Corneal Endothelial Dystrophy, Fuchs Endothelial Corneal Dystrophy, Pseudophakic Bullous Keratopathy | Phase 1 / Phase 2 | 2020-08-19 |